Phenytoin Sodium 200mg Extended-Release Tablets

High-strength 200mg extended-release tablets of phenytoin sodium for once-daily dosing in chronic epilepsy treatment. Meets HTS 3004.90.92.39 criteria as a CNS anticonvulsant containing phenytoin salts in measured retail doses.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3002.13.00Same rate: Free

If immunological modifier rather than anticonvulsant

Chapter excludes heading 3002 immunologicals; primary use determines chapter placement.

3004.20.00Same rate: Free

If sold as mixed kit with syringes for institutional use

Medicaments mixed for specific treatments may shift if not retail-packed.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Document pharmacokinetic profiles proving 24-hour release for classification support

Comply with USP dissolution testing standards in import samples

Avoid bulk packing; must be ≤100 units per retail container

Related Products under HTS 3004.90.92.39

Phenytoin Sodium Extended-Release Capsules 100mg

These extended-release capsules contain 100mg of phenytoin sodium, an anticonvulsant used to control seizures in epilepsy patients. Classified under HTS 3004.90.92.39 as a mixed or unmixed medicament in measured doses for therapeutic use, primarily affecting the central nervous system as an anticonvulsant containing phenytoin salts.

Dilantin 30mg Chewable Tablets

Dilantin chewable tablets with 30mg phenytoin sodium are designed for pediatric epilepsy patients who have difficulty swallowing capsules. This product falls under HTS 3004.90.92.39 due to its phenytoin salt content, measured dosing, and retail packaging for central nervous system anticonvulsant therapy.

Phenytoin Sodium 50mg/5ml Oral Suspension

This liquid oral suspension delivers 50mg phenytoin sodium per 5ml dose, ideal for patients requiring adjustable dosing for seizure management. It qualifies for HTS 3004.90.92.39 as a therapeutic anticonvulsant in measured form containing phenytoin salts, put up for retail sale.

Generic Phenytoin 100mg Immediate-Release Tablets

Immediate-release tablets containing 100mg phenytoin for rapid absorption in acute seizure control. Classified in HTS 3004.90.92.39 for its role as a sedative-hypnotic anticonvulsant with phenytoin, in retail measured doses.

Epilexil Phenytoin 125mg/5ml Pediatric Suspension

Epilexil brand pediatric suspension with 125mg phenytoin per 5ml for infant seizure prophylaxis. Falls under HTS 3004.90.92.39 as a prophylactic anticonvulsant containing phenytoin salts in measured liquid doses for retail.

Phenytoin Sodium 300mg Extended-Release Capsules

Maximum strength 300mg extended-release phenytoin capsules for severe epilepsy management. Classified HTS 3004.90.92.39 for phenytoin salt content as CNS anticonvulsant in retail measured form.